Here is a good article from the Philadelphia Inquirer. According to the article, Avandia sales dipped by 55% in the 4th quarter of 2007, which has caused GSK a bit of heartburn. http://www.philly.com/inquirer/business/20080208_Glaxos_quarterly_earnings_drop_10_.html
Posted by Louisville, Kentucky lawyer: Larry Jones 1-888-KYLAW22
